Search

Author/Creator D'Adamio, Simone

3. Guselkumab for the treatment of psoriasis: a 60-week real-life multicenter retrospective experience. (2nd December 2022)

Authors:
Bardazzi, Federico; Viviani, Filippo; Merli, Yuri; Di Lernia, Vito; Peccerillo, Francesca; Conti, Andrea; Lasagni, Claudia; Tabanelli, Michela; D'Adamio, Simone; Di Nuzzo, Sergio; Cortellazzi, Chiara; Filippi, Federica
Journal:
Expert opinion on biological therapy
Issue:
Volume 22:Number 12(2022)
Page Start:
1561
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. In which patients the best efficacy of secukinumab? Update of a real-life analysis after 136 weeks of treatment with secukinumab in moderate-to-severe plaque psoriasis. (1st February 2020)

Authors:
Galluzzo, Marco; D'Adamio, Simone; Silvaggio, Dionisio; Lombardo, Paolo; Bianchi, Luca; Talamonti, Marina
Journal:
Expert opinion on biological therapy
Issue:
Volume 20:Number 2(2020)
Page Start:
173
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Secukinumab in moderate-to-severe plaque psoriasis: a multi-center, retrospective, real-life study up to 52 weeks observation. (3rd July 2018)

Authors:
Galluzzo, Marco; Talamonti, Marina; De Simone, Clara; D'Adamio, Simone; Moretta, Gaia; Tambone, Sara; Caldarola, Giacomo; Fargnoli, Maria Concetta; Peris, Ketty; Bianchi, Luca
Journal:
Expert opinion on biological therapy
Issue:
Volume 18:Number 7(2018)
Page Start:
727
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗